Marisa Miraldo
Marisa Miraldo
Associate Professor in Health Economics, Business School, Imperial College London
Verified email at imperial.ac.uk - Homepage
TitleCited byYear
Unicondylar knee arthroplasty in the UK National Health Service: an analysis of candidacy, outcome and cost efficacy
CA Willis-Owen, K Brust, H Alsop, M Miraldo, JP Cobb
The Knee 16 (6), 473-478, 2009
1702009
Effects of reference pricing in pharmaceutical markets
MM Galizzi, S Ghislandi, M Miraldo
Pharmacoeconomics 29 (1), 17-33, 2011
842011
Reference pricing and firms’ pricing strategies
M Miraldo
Journal of Health Economics 28 (1), 176-197, 2009
542009
Who is more likely to use doctor-rating websites, and why? A cross-sectional study in London
MM Galizzi, M Miraldo, C Stavropoulou, M Desai, W Jayatunga, M Joshi, ...
BMJ open 2 (6), e001493, 2012
442012
Are English treatment centres treating less complex patients?
A Street, P Sivey, A Mason, M Miraldo, L Siciliani
Health Policy 94 (2), 150-157, 2010
362010
Socio-psychological factors driving adult vaccination: a qualitative study
A Wheelock, A Parand, B Rigole, A Thomson, M Miraldo, C Vincent, ...
PLoS One 9 (12), e113503, 2014
342014
The incentive effects of payment by results
M Miraldo, M Goddard, PC Smith
Centre for Health Economics, University of York Working Papers, 2006
322006
Exploring the responsiveness of public and private hospitals in Lagos, Nigeria
T Adesanya, O Gbolahan, O Ghannam, M Miraldo, B Patel, R Verma, ...
Journal of public health research 1 (1), 2, 2012
312012
Giving greater financial independence to hospitals—does it make a difference? The case of English NHS trusts
G Marini, M Miraldo, R Jacobs, M Goddard
Health Economics 17 (6), 751-775, 2008
312008
In sickness but not in wealth: field evidence on patients’ risk preferences in financial and health domains
MM Galizzi, M Miraldo, C Stavropoulou
Medical Decision Making 36 (4), 503-517, 2016
222016
Should prospective payments be differentiated for public and private healthcare providers?
A Mason, A Street, M Miraldo, L Siciliani
Health Economics, Policy and Law 4 (4), 383-403, 2009
222009
Price adjustment in the hospital sector
M Miraldo, L Siciliani, A Street
Journal of Health Economics 30 (1), 112-125, 2011
202011
Establishing a fair playing field for payment by results
A Mason, M Miraldo, L Siciliani, P Sivey, A Street
Centre for Health Economics, University of York, 2008
142008
Doctor–patient differences in risk and time preferences: A field experiment
MM Galizzi, M Miraldo, C Stavropoulou, M Van Der Pol
Journal of health economics 50, 171-182, 2016
112016
What do we really know about reference pricing for pharmaceuticals
MM Galizzi, S Ghislandi, M Miraldo
Eurohealth 17 (1), 17-19, 2011
112011
Reference pricing in Finnish pharmaceutical markets. Pre-policy evaluation
M Galizzi, S Gishlandi, J Hokkanen, A Kangasharju, I Linnosmaa, ...
Sosiaali-ja terveysministeriö, 2009
112009
Hospital financing and the development and adoption of new technologies
M Miraldo
Centre for Health Economics, University of York, 2007
112007
Reference pricing versus co-payment in the pharmaceutical industry:: price, quality and market coverage
M Miraldo
Centre for Health Economics, University of York, 2007
102007
The effects of hospitals’ governance on optimal contracts: Bargaining vs. contracting
MM Galizzi, M Miraldo
Journal of health economics 30 (2), 408-424, 2011
92011
The determinants of cost-effectiveness potential: An historical perspective on lipid-lowering therapies
RR Camejo, C McGrath, M Miraldo, F Rutten
Pharmacoeconomics 31 (5), 445-454, 2013
82013
The system can't perform the operation now. Try again later.
Articles 1–20